MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

Articles tagged "Olfactory dysfunction"

  • 2023 International Congress

    motor and non-motor correlates of hyposmia detected by the italian olfactory identification test (ioit) in an italian cohort of parkinson’s disease patients

    A. Mechelli, N. Tambasco, M. Filidei, C. Maremmani, M. Pierini, P. Nigro, S. Simoni, L. Parnetti (Catanzaro, Italy)

    Objective: To characterize olfaction in a cohort of PD patients and to investigate the relationship between olfactory impairment with both motor and non-motor features and other clinical characteristics…
  • 2023 International Congress

    Comparison of original and revised versions of the University of Pennsylvania Smell Identification Test

    M. Brumm, K. Pierz, W. Aamodt, C. Gochanour, R. Kurth, C. Coffey, T. Foroud, E. Brown, R. Doty, T. Simuni, C. Tanner, K. Marek, A. Siderowf (Iowa City, USA)

    Objective: To assess agreement between the original and revised versions of the University of Pennsylvania Smell Identification Test (UPSIT). Background: Recently published age/sex-specific UPSIT percentiles,…
  • 2023 International Congress

    An objective shortened 5-item smell test: determinants of performance and agreement with subjective assessment

    Z. Markovic-Obiago, J. Bestwick, H. Chohan, C. Simonet, A. Shrag, A. Noyce (London, United Kingdom)

    Objective: 1) To assess the determinants of hyposmia on a 5-item smell test. 2) To assess the agreement between a 5-item smell test and subjective self-assessment…
  • 2023 International Congress

    Widespread Synuclein pathology in hyposmics precedes dopamine transporter deficit in PARS

    K. Marek, D. Russell, L. Concha, C. Caspell-Garcia, E. Brown, M. Brumm, C. Choi, M. Stern, D. Jennings, C. Soto, A. Siderowf (New Haven, USA)

    Objective: The Parkinson Associated Risk syndrome (PARS) study is designed to identify a Parkinson disease (PD) biomarker/clinical marker derived cohort enriched to develop typical symptoms…
  • 2022 International Congress

    Melatonin attenuates the bidirectional Gut-Brain axis mediated inflammation caused by Ambient Particulate Matter (PM2.5) and averts neurodegeneration

    SAM. Panda, VGM. Naidu (Guwahati, India)

    Objective: To explore the therapeutic potential of melatonin in attenuating the PM2.5 induced inflammation and neurodegeneration through the Gut-brain axis in C57BL/6 mice. Background: The…
  • 2022 International Congress

    CORRELATION BETWEEN OLFACTORY DYSFUNCTION AND INTENSITY OF TREMOR

    D D. Pokhabov, V. Abramov, M. Sadovsky, D V. Pokhabov (Krasnoyarsk, Russian Federation)

    Objective: Our aim was to obtain tremor data of PD and ET patients and the results of their olfactory function, which can help verify our…
  • 2022 International Congress

    Patients with Parkinson’s Disease Share a Unique Olfactory Perceptual Fingerprint

    M. Andelman-Gur, K. Snitz, A. Ravia, N. Hezi, A. Ezra, D. Klepikov, T. Gurevich, N. Sobel (Rehovot, Israel)

    Objective: To explore potential olfactory biomarkers for early detection of Parkinson's disease Background: Although the olfactory decline in Parkinson’s disease (PD) precedes the motor symptoms…
  • 2022 International Congress

    Olfactory Network Reorganization in Parkinson’s Disease

    L. Pesantez Pacheco, M. Saqib, D. Ehrlich, M. Hallett, S. Horovitz (Bethesda, USA)

    Objective: To explore changes in the organization and functionality of the olfactory network in patients with Parkinson’s Disease (PD) using graph theory-based network analysis on…
  • 2022 International Congress

    Olfactory dysfunction in patients with Huntington disease

    J. Patino, H. Coco, S. Zadegan, S. Chandra, N. Karagas, N. Rocha, K. Anderson, A. Teixeira, E. Furr Stimming (Houston, USA)

    Objective: To investigate olfactory dysfunction (OD) in individuals with Huntington disease (HD) and its relation to disease severity. Background: HD is a hereditary neurodegenerative disease…
  • MDS Virtual Congress 2021

    Serial olfactory testing for the diagnosis of prodromal Parkinson disease in the Parkinson Associated Risk Syndrome (PARS) study

    P. Vaswani, J. Morley, D. Jennings, A. Siderowf, K. Marek, P. Investigators (Philadelpiha, USA)

    Objective: To assess whether repeat olfactory testing in initially hyposmic subjects improves prediction of conversion to Parkinson disease (PD). Background: Hyposmia is a common prodromal…
  • « Previous Page
  • 1
  • 2
  • 3
  • 4
  • 5
  • …
  • 14
  • Next Page »

Most Viewed Abstracts

  • This Week
  • This Month
  • All Time
  • Kratom withdrawal induced orobuccal dyskinesia
  • Welcome to the MDS Abstracts Site
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • Effect of Ketone Ester Supplementation on Motor and Non-Motor symptoms in Parkinson's Disease
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • Effect of marijuana on Essential Tremor: A case report
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Estimation of the 2020 Global Population of Parkinson’s Disease (PD)
  • Patients with Essential Tremor Live Longer than their Relatives
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley